Drug intelligence / Profile preview

oliclinomel n4

Development stage
Unknown
Lead developer
Baxter
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Oliclinomel N4 is a triple-chamber parenteral nutrition (PN) formulation developed by Baxter Healthcare. It is designed to provide a balanced supply of macronutrients—including amino acids, dextrose (glucose), and a lipid emulsion (typically a mixture of olive oil and soybean oil)—along with essential electrolytes for patients who are unable to meet their nutritional requirements through oral or enteral routes. The product is supplied in a multi-chamber bag that keeps the components separate until administration, at which point the seals are broken to create a homogenous emulsion for intravenous infusion. The N4 variant is specifically formulated with a defined nitrogen-to-energy ratio to support the metabolic needs of hospitalized adults requiring nutritional support.

Brand names
Oliclinomel N4Oliclinomel
Other names
triple-chamber parenteral nutrition3-in-1 parenteral nutrition

Beyond the preview

Go deeper on oliclinomel n4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oliclinomel n4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call